Varex Imaging (VREX) Expected to Announce Earnings on Thursday

Varex Imaging (NASDAQ:VREX) is expected to be posting its Q1 2026 results before the market opens on Thursday, February 5th. Analysts expect Varex Imaging to post earnings of $0.14 per share and revenue of $207.8250 million for the quarter. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. Individuals may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Tuesday, February 10, 2026 at 5:00 PM ET.

Varex Imaging (NASDAQ:VREX) last issued its earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.19. The business had revenue of $228.90 million for the quarter, compared to the consensus estimate of $219.26 million. Varex Imaging had a negative net margin of 8.32% and a positive return on equity of 7.19%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Trading Down 0.7%

NASDAQ VREX opened at $13.98 on Thursday. The company has a quick ratio of 1.83, a current ratio of 3.43 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $586.04 million, a P/E ratio of -8.22 and a beta of 0.86. Varex Imaging has a 52-week low of $6.76 and a 52-week high of $15.46. The firm has a 50-day moving average price of $12.34 and a 200 day moving average price of $11.32.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. The Manufacturers Life Insurance Company boosted its position in shares of Varex Imaging by 10.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock worth $133,000 after buying an additional 1,442 shares in the last quarter. Comerica Bank raised its position in Varex Imaging by 9.3% during the third quarter. Comerica Bank now owns 20,363 shares of the company’s stock worth $253,000 after acquiring an additional 1,726 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Varex Imaging by 18.5% in the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares in the last quarter. Nebula Research & Development LLC grew its position in shares of Varex Imaging by 11.0% in the second quarter. Nebula Research & Development LLC now owns 22,795 shares of the company’s stock valued at $198,000 after purchasing an additional 2,250 shares during the last quarter. Finally, Rhumbline Advisers increased its stake in shares of Varex Imaging by 4.6% during the 2nd quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock worth $536,000 after purchasing an additional 2,694 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on VREX. B. Riley reissued a “buy” rating and set a $16.00 target price on shares of Varex Imaging in a research note on Wednesday, November 19th. Wall Street Zen upgraded Varex Imaging from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a report on Monday, December 29th. Finally, Oppenheimer lowered their price target on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 19th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $17.00.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.